|
Quotes & Info
|
| ACTC > SEC Filings for ACTC > Form 8-K on 2-Mar-2012 | All Recent SEC Filings |
2-Mar-2012
Results of Operations and Financial Condition
On March 1, 2012, Advanced Cell Technology, Inc. (the "Company") issued a press release announcing its financial results for the year ended December 31, 2011 and certain other information, including certain information regarding a proposed reverse stock split. A copy of the Company's press release announcing these financial results and certain other information is attached hereto as Exhibit 99.1.
Additional Information and Where to Find It
The Company has filed with the Securities and Exchange Commission (the "SEC") a
preliminary proxy statement in connection with the Company's proposal to effect
a reverse stock split. The Company plans to file a definitive proxy statement
with the SEC and furnish such definitive proxy statement to stockholders of
record on the record date for the meeting at which stockholders will be asked to
approve the proposed reverse stock split. The Company, Mr. Rabin and certain of
its directors, executive officers and other members of management may, under SEC
rules, be deemed "participants" in the solicitation of proxies from the
Company's stockholders with respect to the proposed reverse stock split.
INVESTORS AND STOCKHOLDERS ARE ADVISED TO READ THE DEFINITIVE PROXY STATEMENT
AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC WHEN THEY BECOME AVAILABLE
BECAUSE THOSE DOCUMENTS WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED
REVERSE STOCK SPLIT ABOUT THE PROPOSAL AND OTHER IMPORTANT INFORMATION INCLUDING
THOSE PERSONS WHO MAY BE DEEMED "PARTICIPANTS" IN THE SOLICITATION. Investors
and stockholders may obtain a free copy of the definitive proxy statement when
it becomes available, and other documents filed by the Company with the SEC,
including the preliminary proxy statement, at the SEC's web site at
http://www.sec.gov. Free copies of the definitive proxy statement, when it
becomes available, and the Company's other filings with the SEC may also be
obtained from the Company by directing a request to Advanced Cell Technology,
Inc., 33 Locke Drive, Marlborough, Massachusetts 01752, Attention: Secretary.
|
|